Aignostics Stock
Aignostics is a precision pathology company leveraging AI-powered image analysis to enhance diagnostic accuracy and improve patient outcomes. Based out of Berlin, Germany, its technology combines machine learning and pathology expertise to support drug development and optimize clinical workflows.
Founded: 2018
For more Aignostics stock information, or to buy or sell private shares, sign up for a MicroVentures account.
Management Team
| Viktor Matyas Chief Executive Officer and Co-Founder |
| Maximilian Alber Chief Technology Officer and Co-Founder |
